Headache Relief to Go

Description

Acetaminophen and caffeine are combined in a formulation designed as a pain reliever and adjuvant. This product is presented in the FAST POWDERS™ dosage form, which allows for administration without the need for liquid. The powder can be poured directly into the mouth, providing a convenient option for users. The formulation is flavored with sweet orange and is distributed by UrgentRx. Each unit consists of one powder pack.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with headache and muscular aches.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are instructed to place one powder on the tongue and swallow, with or without water. This dosage may be repeated every 4 to 6 hours as needed while symptoms persist. It is imperative that patients do not exceed a total of six pouches within a 24-hour period.

For children under 12 years of age, it is recommended to consult a physician for appropriate dosing guidance.

Patients should adhere strictly to the recommended dosages and frequency to avoid the risk of overdose.

Contraindications

Use is contraindicated in patients with a known allergy to acetaminophen. Additionally, concurrent use with any other medication containing acetaminophen, whether prescription or nonprescription, is prohibited. If there is uncertainty regarding the presence of acetaminophen in a medication, consultation with a healthcare professional is advised.

Warnings and Precautions

This product contains acetaminophen, which poses a risk of severe liver damage under certain conditions. Healthcare professionals should advise patients that the maximum daily dosage is limited to 6 powders within a 24-hour period. Patients must be cautioned against concurrent use with other medications containing acetaminophen, as well as the consumption of 3 or more alcoholic drinks daily while using this product.

Patients with liver disease should consult a healthcare provider prior to use. Additionally, those taking the anticoagulant warfarin should seek guidance from a doctor or pharmacist before starting this product. It is also recommended to limit the intake of caffeine-containing drugs, foods, or beverages during treatment, as excessive caffeine may lead to symptoms such as nervousness, irritability, sleeplessness, and, in some cases, rapid heartbeat.

In the event of an overdose, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay. Prompt medical attention is crucial for both adults and children, even if no signs or symptoms are initially apparent.

Patients should discontinue use and consult a healthcare professional if any of the following occur: worsening pain or pain lasting longer than 10 days, fever that worsens or persists for more than 3 days, the emergence of new symptoms, or the presence of redness or swelling. These symptoms may indicate a serious underlying condition that requires further evaluation.

Side Effects

Severe liver damage may occur in patients taking this product containing acetaminophen if they exceed the maximum daily amount of six powders within a 24-hour period, use it in conjunction with other drugs containing acetaminophen, or consume three or more alcoholic drinks daily while using this product. Patients with a known allergy to acetaminophen should not use this product, nor should it be used with any other drug containing acetaminophen, whether prescription or nonprescription. If patients are uncertain whether a drug contains acetaminophen, they are advised to consult a doctor or pharmacist.

Patients with liver disease should seek medical advice before using this product. Additionally, those taking the blood-thinning medication warfarin should consult a healthcare professional prior to use.

While using this product, patients are advised to limit the intake of caffeine-containing drugs, foods, or beverages, as excessive caffeine may lead to symptoms such as nervousness, irritability, sleeplessness, and, in some cases, rapid heartbeat.

Patients should discontinue use and consult a doctor if pain worsens or persists for more than 10 days, if fever worsens or lasts longer than 3 days, if new symptoms arise, or if redness or swelling occurs, as these may indicate a serious condition.

An overdose of this product may result in liver damage. In the event of an overdose, it is crucial for patients to seek medical assistance or contact a Poison Control Center immediately, as prompt medical attention is essential for both adults and children, even if no signs or symptoms are initially apparent.

Drug Interactions

Patients should consult a healthcare professional prior to using this product if they are concurrently taking warfarin, a blood-thinning medication. The combination may necessitate careful monitoring due to potential interactions that could affect anticoagulation efficacy.

Caution is advised regarding the concurrent use of caffeine-containing products, including drugs, foods, or beverages. Excessive caffeine intake may lead to adverse effects such as nervousness, irritability, insomnia, and, in some cases, tachycardia. It is recommended to limit caffeine consumption while using this product to mitigate these risks.

This product should not be used in conjunction with any other medications that contain acetaminophen, whether prescription or over-the-counter. Patients uncertain about the acetaminophen content in their medications should seek guidance from a healthcare professional to avoid unintentional overdose.

Packaging & NDC

Below are the non-prescription pack sizes of Headache Relief to Go (acetaminophen and caffeine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. It is important to assess the appropriateness of treatment and dosage for this age group, as specific recommendations may vary based on individual health needs and conditions.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure the safety of both the mother and the developing fetus.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment should consult a healthcare professional prior to using this product. The formulation contains acetaminophen, which poses a risk of severe liver damage under certain conditions. Specifically, patients should not exceed six powders within a 24-hour period, as this represents the maximum daily dosage. Additionally, concurrent use with other medications containing acetaminophen is contraindicated, as it may increase the risk of liver injury.

Patients with compromised liver function are also advised to limit alcohol consumption to fewer than three alcoholic drinks per day while using this product, as excessive alcohol intake can exacerbate the potential for liver damage.

In the event of an overdose, which may occur if the recommended dosage is exceeded, immediate medical assistance should be sought. It is crucial for both adults and children to receive prompt medical attention, even in the absence of noticeable signs or symptoms of overdose. Monitoring liver function and adherence to recommended dosages is essential to mitigate the risk of hepatotoxicity in patients with hepatic impairment.

Overdosage

In cases of overdose, the potential for liver damage increases significantly when the recommended dose is exceeded. It is imperative that healthcare professionals recognize the seriousness of this situation and act promptly.

Immediate medical assistance is crucial. In the event of an overdose, individuals should seek medical help or contact a Poison Control Center without delay. This recommendation applies to both adults and children, as timely intervention can be critical, even in the absence of noticeable signs or symptoms.

Healthcare providers should be vigilant in monitoring for any indications of liver impairment and ensure that appropriate management procedures are initiated as soon as possible.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. Patients should be informed not to use the product if they have a known allergy to acetaminophen. It is important to emphasize that patients should not use this medication in conjunction with any other drug containing acetaminophen, whether prescription or nonprescription. If patients are uncertain about the contents of a medication, they should be encouraged to consult a doctor or pharmacist for clarification.

Patients should be instructed to stop using the product and seek medical advice if their pain worsens or persists for more than 10 days. Similarly, if a fever worsens or lasts longer than 3 days, or if new symptoms develop, patients should be advised to discontinue use and consult a healthcare professional. Additionally, the presence of redness or swelling should prompt patients to stop using the medication and seek medical attention, as these may indicate a serious condition.

While using this product, patients should limit their intake of caffeine-containing drugs, foods, or beverages, as excessive caffeine may lead to nervousness, irritability, sleeplessness, and, in some cases, rapid heartbeat. It is also crucial for patients to consult a doctor before using this medication if they have liver disease. Furthermore, patients taking the blood-thinning medication warfarin should be advised to speak with a doctor or pharmacist prior to using this product.

Storage and Handling

The product is supplied in pouches, and it is imperative that the pouches remain intact. The product should not be used if the pouch is torn or open, as this may compromise the integrity and safety of the contents.

For optimal storage, the product should be kept in a cool, dry place, away from direct sunlight and moisture. Specific temperature ranges for storage are not provided; however, it is advisable to maintain a stable environment to ensure product efficacy.

Care should be taken during handling to avoid any damage to the pouches, as this could lead to contamination or degradation of the product.

Additional Clinical Information

The medication is administered orally, with patients instructed to place one powder on the tongue and swallow it with or without water. Dosing can be repeated every 4 to 6 hours as needed, but should not exceed 6 pouches within a 24-hour period.

Clinicians should counsel patients to consult a doctor prior to use if they have liver disease or are taking the blood-thinning medication warfarin. Additionally, pregnant or breastfeeding patients are advised to seek guidance from a health professional before using the product. No further information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Headache Relief to Go, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)